New Management Strategies of Hormone Refractory Prostate Cancer (HRPC)

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

New treatment strategies in the management of hormone refractory prostate cancer (HRPC): only chemotherapy?

Prostate cancer progression to androgen ablation refractory stage D3 corresponds to cancer cell escape from androgen withdrawal-induced apoptosis. In this development, enhancement of growth factor stimulation has an essential role in the upregulation of survival signals and constitutive proliferation [1]. The mainstay of treatment for metastatic prostate cancer is androgen deprivation. Unfortun...

متن کامل

Polyamine-reduced diet in metastatic hormone-refractory prostate cancer (HRPC) patients.

Polyamine (PA) deprivation is effective in prostate carcinoma models. We have assessed the observance by patients, tolerance and side effects of a PA-reduced diet (PRD) and intestinal decontamination (ID), in order to reduce PA dietary and intestinal bacterial pools, in metastatic, hormone-refractory prostate cancer (HRPC) patients. A total of 13 volunteers (mean age, 67+/-10 years) with metast...

متن کامل

Management of Hormone-Sensitive and Hormone-Refractory Metastatic Prostate Cancer.

BACKGROUND: Prostate cancer is a significant health problem in the United States and is the focus of increasing attention in our society. With the aging of the US population, it is likely that prostate cancer will continue to grow in importance. The options for systemic therapy of metastatic prostate cancer should be familiar to physicians, including nonspecialists, whose patients seek their ad...

متن کامل

Management of patients with hormone refractory prostate cancer.

Prostate cancer is the second most common cancer in men in the UK, and the incidence of prostate cancer has increased dramatically over the past two decades. Although most men are diagnosed at early stage, more than 50% develop locally advanced or metastatic disease. Androgen ablation with luteinising hormone-releasing hormone (LHRH) agonists alone, or in combination with anti-androgens, is the...

متن کامل

New Strategies for Prostate Cancer Management

Scott Eggener, The University of Chicago Medicine, Chicago, IL, USA Mark Emberton, University College London Hospital, London, UK Vikas Gulani, Case Western Reserve University, Cleveland, OH, USA Christof Kastner, Addenbrooke’s Hospital, Cambridge, UK Laurence Klotz, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Aytekin Oto, The University of Chicago Medicine, Chicago, IL, USA Anwar Pa...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Bangladesh College of Physicians and Surgeons

سال: 1970

ISSN: 1015-0870

DOI: 10.3329/jbcps.v26i2.4180